The goal of this research study is to evaluate the safety and efficacy of the rivastigmine transdermal patch in patients with probable Alzheimer's Disease.

Condition	Treatment or Intervention	Phase
Alzheimer's Disease Dementia, Alzheimer Type	Drug: rivastigmine transdermal patch	Phase III

Further Study Details: 

Ages Eligible for Study:  50 Years   -   85 Years,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

• Diagnosis of dementia of the Alzheimer's type
• Males, and females who are surgically sterile or one year postmenopausal
• A primary caregiver willing to accept responsibility for supervising the treatment

Exclusion Criteria:

• Any condition (other than Alzheimer's) that could explain patient's dementia
• An advanced, severe or unstable disease that may put the patient at special risk
• Current diagnosis of active, uncontrolled seizure disorder or unstable cardiovascular disease

Please use the link below for contact information      862-778-8300 

California
      San Francisco,  California,  94109,  United States; Recruiting
      Orange,  California,  92868-3298,  United States; Recruiting
Florida
      Fort Lauderdale,  Florida,  33321,  United States; Recruiting
      Boca Raton,  Florida,  33486,  United States; Recruiting
      Miami Beach,  Florida,  33154,  United States; Recruiting
      West Palm Beach,  Florida,  33407,  United States; Recruiting
      Port Charlotte,  Florida,  33952,  United States; Recruiting
      Miami,  Florida,  33137,  United States; Not yet recruiting
Georgia
      Snellville,  Georgia,  30078,  United States; Recruiting
Missouri
      St. Louis,  Missouri,  63104,  United States; Recruiting
Nebraska
      Omaha,  Nebraska,  68131,  United States; Recruiting
New Jersey
      Long Branch,  New Jersey,  07740,  United States; Recruiting
      Manchester,  New Jersey,  08759,  United States; Recruiting
      Toms River,  New Jersey,  08755,  United States; Recruiting
Ohio
      Dayton,  Ohio,  45415,  United States; Recruiting
      Columbus,  Ohio,  43215,  United States; Recruiting
Oklahoma
      Oklahoma City,  Oklahoma,  73118,  United States; Recruiting
Pennsylvania
      Greensburg,  Pennsylvania,  15601,  United States; Recruiting
Tennessee
      Nashville,  Tennessee,  37203,  United States; Recruiting
Texas
      Austin,  Texas,  78756,  United States; Recruiting
      Houston,  Texas,  77030,  United States; Recruiting
      Houston,  Texas,  77030,  United States; Not yet recruiting
Washington
      Tacoma,  Washington,  98405,  United States; Recruiting
Chile
      Santiago,  Chile; Recruiting
      Valparaiso,  Chile; Recruiting
Czech Republic
      Prague,  Czech Republic; Recruiting
      Brno,  Czech Republic; Recruiting
      Olomouc,  Czech Republic; Recruiting
      Brno-Bohunice,  Czech Republic; Recruiting
      HRADEC KRALOVE,  Czech Republic; Recruiting
Denmark
      Kobenhavn,  Denmark; Recruiting
      Glostrup,  Denmark; Recruiting
      Hillerod,  Denmark; Recruiting
Finland
      Kuopio,  Finland; Recruiting
Guatemala
      Guatemala City,  Guatemala; Recruiting
Israel
      Petach Tikva,  Israel; Recruiting
      Hifa,  Israel; Recruiting
      Beersheva,  Israel; Recruiting
      Jerusalem,  Israel; Recruiting
      Tel Aviv,  Israel; Recruiting
Italy
      Pescara,  Italy; Recruiting
      Lido di Camaiore,  Italy; Recruiting
      Milano,  Italy; Recruiting
Korea, Republic of
      Chungbuk,  Korea, Republic of; Recruiting
      Seoul,  Korea, Republic of; Recruiting
      KyungKi-province,  Korea, Republic of; Recruiting
Mexico
      Mexico, D.F.,  Mexico; Recruiting
      Guadalajara Jalisco,  Mexico; Recruiting
      Monterrey Nuevo Leon,  Mexico; Recruiting
Norway
      Tromso,  Norway; Recruiting
      Bodo,  Norway; Recruiting
      Trondheim,  Norway; Recruiting
      Oslo,  Norway; Recruiting
Peru
      Lima,  Peru; Recruiting
Poland
      Warszawa,  Poland; Recruiting
      Gdansk,  Poland; Recruiting
      Lublin,  Poland; Recruiting
      Szczecin,  Poland; Recruiting
      Poznan,  Poland; Recruiting
Portugal
      Coimbra,  Portugal; Recruiting
      Amadora,  Portugal; Recruiting
Puerto Rico
      Bayamon,  00959,  Puerto Rico; Recruiting
Russian Federation
      Moscow,  Russian Federation; Recruiting
      Saint Petersburg,  Russian Federation; Recruiting
Slovakia
      Bratislava,  Slovakia; Recruiting
      Michalovce,  Slovakia; Recruiting
Sweden
      Stockholm,  Sweden; Recruiting
      Uppsala,  Sweden; Recruiting
      Kalmar,  Sweden; Recruiting
      Goteborg,  Sweden; Recruiting
Taiwan, Province of China
      Taipei,  Taiwan, Province of China; Recruiting
      Tao-Yuan,  Taiwan, Province of China; Recruiting
      Taichung,  Taiwan, Province of China; Recruiting
      Kaohsiung,  Taiwan, Province of China; Recruiting
Venezuela, Estado Merida
      Ciudad Merida,  Estado Merida,  Venezuela; Recruiting

Study ID Numbers:  CENA713D2320
Record last reviewed:  April 2005
Last Updated:  April 6, 2005
Record first received:  December 10, 2004
ClinicalTrials.gov Identifier:  NCT00099242
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08